Ronni L. Weinkauf, Ph.D.
VP, Global Research & Development
NeoStrata Company, Inc., Princeton, NJ
Ronni Weinkauf, VP of NeoStrata’s Global Research
and Development team, began her career with Unilever R&D in 1993 as a
Research Scientist in the Clinical Research and Appraisal department. Through her nearly 15 year tenure with
Unilever, Ronni not only lead the Clinical Research team and the Skin Cleansing
and Care clinical program, but also held senior Program management roles within
the Skin Cleansing and Skin Care Research Program. Ronni was Global Anti-Aging Program Director, leading all anti-aging
and anti-irritant research efforts in the US, Europe and Asia.
Ronni’s program delivered numerous
patent protected new technologies, products, claims, driving growth for the
Pond’s, Dove, as well Elizabeth Arden brands. In 2007, Ronni joined the NeoStrata Company as VP of
Research & Development and an executive member of NeoStrata’s leadership
team. The NeoStrata company, is a
dermatology based skin research & development company. The founders of NeoStrata pioneered and
patented the use of Alpha Hydroxy Acids for the treatment and reversal of Aging
Skin. The NeoStrata company
continues to identify and develop new generation anti-aging technology for both
the NeoStrata branded products as well as partnership within the industry. As VP of Global Research &
Development, Ronni leads new technology development and product development
programs which support the company’s NeoStrata dermatologist dispensed, and
Exuviance and CoverBlend retail brands sold around the world in over 80
countries.
Ronni has a broad based research expertise in
skin structure, function, and repair, primarily in the areas of skin
photodamage and repair, skin lightening, skin inflammation. Ronni holds 13 US patents, 16
international patents, and has authored numerous scientific publications,
poster presentations, as well as co-authoring book chapters and serving as invited
speakers at cosmetic scientific conferences. Ronni received her Bachelors of Science degree in Chemistry
from the University of Delaware, and her Ph.D. in Medicinal Chemistry from
Rutgers, the State University of New Jersey.
STACY S. HAWKINS, Ph.D.
Global Clinical Leader
Unilever R&D USA, Trumbull, CT
Stacy.Hawkins@Unilever.com
Stacy Hawkins, Unilever Global Clinical Leader, Skin
R&D Program began her career with Unilever R&D in 1996 as a research
scientist and group leader of the Clinical Instruments Group in the Clinical
Research and Skin Appraisal department. As Global Clinical leader she develops and delivers global
clinical testing plans for the Skin R&D program. Her current responsibilities include development and
execution of Unilever’s global publication strategy for skin research journals,
key dermatology and industry conferences, and medical and educational
materials. She is also responsible
for linking key research external collaborations to Unilever brand and
educational activities.
Her research expertise includes: understanding
wrinkle morphology and repair with anti-aging therapies; quantifying elasticity
of the skin; clinical and consumer measurement of skin color and texture; role
of skin barrier in maintenance of skin health. Her research has been published in various skin
bioengineering and dermatological publications, and has been used for novel
claims substantiation for Pond’s and Dove skin care products. These publications led to articles
featured in Skin & Aging and Dermatology Times, as well as several invited
talks and book chapters. In
addition, she serves on the Executive Committee of the International Society
for Biophysics and Imaging of the Skin. She received her Bachelors of Science degree from
Massachusetts Institute of Technology in BioElectrical Engineering, and her
Ph.D. from Rutgers, the State University of New Jersey, in Biomedical
Engineering.
Uma Santhanam, Ph.D.
Senior Manager, Cell Biology and In Vitro
Toxicology
Avon Products, Inc. Suffern NY 10901
845-369-2149
Uma.Santhanam@Avon.com
Uma Santhanam joined Avon in 2004 and is a Senior Manager in
Avon’s Cell Biology and In Vitro Toxicology group. In this role, she manages new technology identification, in vitro safety and efficacy testing of
ingredients and formulations, and helps create and substantiate novel claims
for Avon skin care products. Using her extensive skin biology background and cutting-edge
scientific approaches, Dr. Santhanam has helped develop several breakthrough
anti-aging skin care products. Prior to joining Avon, she worked as a Project Leader/Lead
Research Scientist in Unilever Research US in New Jersey. Her research interests include skin aging,
photodamage and its repair, skin pigmentation, and inflammation.
Dr. Santhanam holds a B.S.in Microbiology and Ph.D in
Biochemistry from University of Bombay, India. She completed her post-doctoral training at The Rockefeller
University in New York. Dr.
Santhanam holds a total of fourteen U.S. patents and over twenty international patents
in the field of skincare. She
also has several US and International patents pending. Dr. Santhanam has
over twenty scientific publications, over thirty poster presentations and has
authored a chapter in the book Biotechnology in Personal Care, Cosmetic
Science and Technology Series, Taylor and Francis, New York, NY, 2004. Dr. Santhanam was
recognized for her work at Avon with several awards including The Avon
Chairman’s Award (2010),
Excellence In Execution Award (2010) ,
Matrix Award (2010) and Global R&D Achievement Award (2006,
2007).
Peter Konish
Director, Sensory and Formulation Development
NeoStrata Company, Inc
Peter Konish is the Director
of Sensory and Formulation Development at NeoStrata Company, Inc. Peter is responsible for the development
of novel skin care formulations incorporating the use of alpha hydroxy acids
(ie glycolic & lactic acids), polyhydroxy acids (ie gluconolactone), bionic
acids (ie lactobionic & maltobionic acids), and aminosugars for the
NeoStrata®, Exuviance®, and CoverBlend® skin care brands. Prior to this, Peter
was at L’Oreal where he held the position of Manager of Fine Fragrance
Ancillary Development.
In this role, Peter was responsible for overseeing the
development of skin care and body care formulations to support the Ralph
Lauren, Kiehls, and Lancôme brands. Peter also has a strong background in
polymer chemistry and started out his career at Amerchol Corporation where he
researched the synthesis and application of various natural polymers
derivatives using Chitin, Chitosan, Starch, Guar, and Cellulose for the skin
care and hair care industries. Peter has co-authored numerous scientific
articles in the Journal of Cosmetic Science, Macromolecules and in the ACS
series of Polysaccharide Applications, Volume 737. He has been in the personal
care industry for over 18 years and has extensive experience in skin care
product development. Peter holds a B.S in Chemistry from Monmouth University, a
M.S in Cosmetic Science from Fairleigh Dickinson University, and is an active
member of the New York Chapter of the SCC.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.